These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12771000)

  • 1. Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling.
    Wilson EM; Moainie SL; Baskin JM; Lowry AS; Deschamps AM; Mukherjee R; Guy TS; St John-Sutton MG; Gorman JH; Edmunds LH; Gorman RC; Spinale FG
    Circulation; 2003 Jun; 107(22):2857-63. PubMed ID: 12771000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
    Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
    Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.
    Webb CS; Bonnema DD; Ahmed SH; Leonardi AH; McClure CD; Clark LL; Stroud RE; Corn WC; Finklea L; Zile MR; Spinale FG
    Circulation; 2006 Sep; 114(10):1020-7. PubMed ID: 16923753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted regional injection of biocomposite microspheres alters post-myocardial infarction remodeling and matrix proteolytic pathways.
    Dixon JA; Gorman RC; Stroud RE; Mukherjee R; Meyer EC; Baker NL; Morita M; Hamamoto H; Ryan LP; Gorman JH; Spinale FG
    Circulation; 2011 Sep; 124(11 Suppl):S35-45. PubMed ID: 21911817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
    Mukherjee R; Herron AR; Lowry AS; Stroud RE; Stroud MR; Wharton JM; Ikonomidis JS; Crumbley AJ; Spinale FG; Gold MR
    Am J Cardiol; 2006 Feb; 97(4):532-7. PubMed ID: 16461051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling.
    Apple KA; Yarbrough WM; Mukherjee R; Deschamps AM; Escobar PG; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Stroud RE; O'Neill TP; Spinale FG
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):228-35. PubMed ID: 16495760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial infarct expansion and matrix metalloproteinase inhibition.
    Mukherjee R; Brinsa TA; Dowdy KB; Scott AA; Baskin JM; Deschamps AM; Lowry AS; Escobar GP; Lucas DG; Yarbrough WM; Zile MR; Spinale FG
    Circulation; 2003 Feb; 107(4):618-25. PubMed ID: 12566376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs.
    Etoh T; Joffs C; Deschamps AM; Davis J; Dowdy K; Hendrick J; Baicu S; Mukherjee R; Manhaini M; Spinale FG
    Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H987-94. PubMed ID: 11514263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
    Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP induction and inhibition in myocardial infarction.
    Lindsey ML
    Heart Fail Rev; 2004 Jan; 9(1):7-19. PubMed ID: 14739764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling.
    Su H; Spinale FG; Dobrucki LW; Song J; Hua J; Sweterlitsch S; Dione DP; Cavaliere P; Chow C; Bourke BN; Hu XY; Azure M; Yalamanchili P; Liu R; Cheesman EH; Robinson S; Edwards DS; Sinusas AJ
    Circulation; 2005 Nov; 112(20):3157-67. PubMed ID: 16275862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction.
    Mukherjee R; Snipes JM; Saunders SM; Zavadzkas JA; Spinale FG
    J Surg Res; 2012 Jan; 172(1):59-67. PubMed ID: 20863528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
    Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC
    Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Unloading After Acute Myocardial Infarction Reduces MMP/JNK Associated Apoptosis and Promotes FAK Cell-Survival Signaling.
    Li T; Wei X; Evans CF; Sanchez PG; Li S; Wu ZJ; Griffith BP
    Ann Thorac Surg; 2016 Dec; 102(6):1919-1924. PubMed ID: 27378553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cardiac dysfunction is associated with specific alterations in inflammatory cytokines and matrix metalloproteinases after acute myocardial infarction in sheep.
    Gallagher G; Menzie S; Huang Y; Jackson C; Hunyor SN
    Basic Res Cardiol; 2007 Jan; 102(1):63-72. PubMed ID: 16817025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.
    Lindsey ML; Zamilpa R
    Cardiovasc Ther; 2012 Feb; 30(1):31-41. PubMed ID: 20645986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
    Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
    Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.
    Vanhoutte D; Schellings M; Pinto Y; Heymans S
    Cardiovasc Res; 2006 Feb; 69(3):604-13. PubMed ID: 16360129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term localized high-frequency electric stimulation within the myocardial infarct: effects on matrix metalloproteinases and regional remodeling.
    Mukherjee R; Rivers WT; Ruddy JM; Matthews RG; Koval CN; Plyler RA; Chang EI; Patel RK; Kern CB; Stroud RE; Spinale FG
    Circulation; 2010 Jul; 122(1):20-32. PubMed ID: 20566951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional heterogeneity in determinants of atrial matrix remodeling and association with atrial fibrillation vulnerability postmyocardial infarction.
    Stacy MR; Lin BA; Thorn SL; Lobb DC; Maxfield MW; Novack C; Zellars KN; Freeburg L; Akar JG; Sinusas AJ; Spinale FG
    Heart Rhythm; 2022 May; 19(5):847-855. PubMed ID: 35066183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.